OptimizeRx Corporation (NASDAQ:OPRX) Q1 2023 Earnings Call Transcript May 10, 2023
OptimizeRx Corporation misses on earnings expectations. Reported EPS is $-0.09 EPS, expectations were $-0.08.
Operator: Good afternoon, everyone. And thank you for joining OptimizeRx’s First Quarter Fiscal 2023 Earnings Discussion. With us today is the Chief Executive Officer of OptimizeRx, Will Febbo. He is joined by company Chief Financial and Operating Officer, Ed Stelmakh; Chief Commercial Officer, Steve...
